167 related articles for article (PubMed ID: 27698077)
1. Src Family Kinases Are Regulated in Multiple Myeloma Cells by Phosphatase of Regenerating Liver-3.
Abdollahi P; Vandsemb EN; Hjort MA; Misund K; Holien T; Sponaas AM; Rø TB; Slørdahl TS; Børset M
Mol Cancer Res; 2017 Jan; 15(1):69-77. PubMed ID: 27698077
[TBL] [Abstract][Full Text] [Related]
2. The phosphatase of regenerating liver-3 (PRL-3) is important for IL-6-mediated survival of myeloma cells.
Slørdahl TS; Abdollahi P; Vandsemb EN; Rampa C; Misund K; Baranowska KA; Westhrin M; Waage A; Rø TB; Børset M
Oncotarget; 2016 May; 7(19):27295-306. PubMed ID: 27036022
[TBL] [Abstract][Full Text] [Related]
3. IL6 Promotes a STAT3-PRL3 Feedforward Loop via SHP2 Repression in Multiple Myeloma.
Chong PSY; Zhou J; Lim JSL; Hee YT; Chooi JY; Chung TH; Tan ZT; Zeng Q; Waller DD; Sebag M; Chng WJ
Cancer Res; 2019 Sep; 79(18):4679-4688. PubMed ID: 31337650
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of IL-6-dependent growth of myeloma cells by an acidic peptide repressing the gp130-mediated activation of Src family kinases.
Hausherr A; Tavares R; Schäffer M; Obermeier A; Miksch C; Mitina O; Ellwart J; Hallek M; Krause G
Oncogene; 2007 Jul; 26(34):4987-98. PubMed ID: 17310994
[TBL] [Abstract][Full Text] [Related]
5. Src-mediated phosphorylation of the tyrosine phosphatase PRL-3 is required for PRL-3 promotion of Rho activation, motility and invasion.
Fiordalisi JJ; Dewar BJ; Graves LM; Madigan JP; Cox AD
PLoS One; 2013; 8(5):e64309. PubMed ID: 23691193
[TBL] [Abstract][Full Text] [Related]
6. Deficiency of Fyn protein is prerequisite for apoptosis induced by Src family kinase inhibitors in human mesothelioma cells.
Eguchi R; Kubo S; Takeda H; Ohta T; Tabata C; Ogawa H; Nakano T; Fujimori Y
Carcinogenesis; 2012 May; 33(5):969-75. PubMed ID: 22354875
[TBL] [Abstract][Full Text] [Related]
7. PRL-1 tyrosine phosphatase regulates c-Src levels, adherence, and invasion in human lung cancer cells.
Achiwa H; Lazo JS
Cancer Res; 2007 Jan; 67(2):643-50. PubMed ID: 17234774
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of p53 by phosphatase of regenerating liver 3 is mediated by MDM2 and PIRH2.
Min SH; Kim DM; Heo YS; Kim HM; Kim IC; Yoo OJ
Life Sci; 2010 Jan; 86(1-2):66-72. PubMed ID: 19945467
[TBL] [Abstract][Full Text] [Related]
9. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility.
Fiordalisi JJ; Keller PJ; Cox AD
Cancer Res; 2006 Mar; 66(6):3153-61. PubMed ID: 16540666
[TBL] [Abstract][Full Text] [Related]
10. Activation of src-related tyrosine kinases by IL-3.
Anderson SM; Jorgensen B
J Immunol; 1995 Aug; 155(4):1660-70. PubMed ID: 7636226
[TBL] [Abstract][Full Text] [Related]
11. Endogenous and synthetic inhibitors of the Src-family protein tyrosine kinases.
Chong YP; Ia KK; Mulhern TD; Cheng HC
Biochim Biophys Acta; 2005 Dec; 1754(1-2):210-20. PubMed ID: 16198159
[TBL] [Abstract][Full Text] [Related]
12. The inhibition of SRC family kinase suppresses pancreatic cancer cell proliferation, migration, and invasion.
Je DW; O YM; Ji YG; Cho Y; Lee DH
Pancreas; 2014 Jul; 43(5):768-76. PubMed ID: 24763074
[TBL] [Abstract][Full Text] [Related]
13. A novel signaling pathway associated with Lyn, PI 3-kinase and Akt supports the proliferation of myeloma cells.
Iqbal MS; Tsuyama N; Obata M; Ishikawa H
Biochem Biophys Res Commun; 2010 Feb; 392(3):415-20. PubMed ID: 20079716
[TBL] [Abstract][Full Text] [Related]
14. CUB-domain-containing protein 1 overexpression in solid cancers promotes cancer cell growth by activating Src family kinases.
Leroy C; Shen Q; Strande V; Meyer R; McLaughlin ME; Lezan E; Bentires-Alj M; Voshol H; Bonenfant D; Alex Gaither L
Oncogene; 2015 Oct; 34(44):5593-8. PubMed ID: 25728678
[TBL] [Abstract][Full Text] [Related]
15. Ezrin is a specific and direct target of protein tyrosine phosphatase PRL-3.
Forte E; Orsatti L; Talamo F; Barbato G; De Francesco R; Tomei L
Biochim Biophys Acta; 2008 Feb; 1783(2):334-44. PubMed ID: 18078820
[TBL] [Abstract][Full Text] [Related]
16. Metastasis-associated phosphatase PRL-2 regulates tumor cell migration and invasion.
Wang Y; Lazo JS
Oncogene; 2012 Feb; 31(7):818-27. PubMed ID: 21765462
[TBL] [Abstract][Full Text] [Related]
17. Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis.
Wilson MB; Schreiner SJ; Choi HJ; Kamens J; Smithgall TE
Oncogene; 2002 Nov; 21(53):8075-88. PubMed ID: 12444544
[TBL] [Abstract][Full Text] [Related]
18. The mixed-lineage kinase DLK undergoes Src-dependent tyrosine phosphorylation and activation in cells exposed to vanadate or platelet-derived growth factor (PDGF).
Daviau A; Di Fruscio M; Blouin R
Cell Signal; 2009 Apr; 21(4):577-87. PubMed ID: 19146952
[TBL] [Abstract][Full Text] [Related]
19. Elevated phosphatase of regenerating liver 3 (PRL-3) promotes cytoskeleton reorganization, cell migration and invasion in endometrial stromal cells from endometrioma.
Zhan H; Ma J; Ruan F; Bedaiwy MA; Peng B; Wu R; Lin J
Hum Reprod; 2016 Apr; 31(4):723-33. PubMed ID: 26874360
[TBL] [Abstract][Full Text] [Related]
20. Activation of Src in human breast tumor cell lines: elevated levels of phosphotyrosine phosphatase activity that preferentially recognizes the Src carboxy terminal negative regulatory tyrosine 530.
Egan C; Pang A; Durda D; Cheng HC; Wang JH; Fujita DJ
Oncogene; 1999 Feb; 18(5):1227-37. PubMed ID: 10022129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]